Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-06

Clinical Trial Update: Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

View source ↗

Summary

Update on a completed non-interventional study evaluating palliative therapy in multiple myeloma using a combination of lenalidomide and dexamethasone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Revlimid (lenalidomide)

Snippet

Sponsor: iOMEDICO AG | Conditions: Multiple Myeloma | Status: COMPLETED